pubmed-article:7055948 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7055948 | lifeskim:mentions | umls-concept:C0027051 | lld:lifeskim |
pubmed-article:7055948 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
pubmed-article:7055948 | lifeskim:mentions | umls-concept:C0010287 | lld:lifeskim |
pubmed-article:7055948 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
pubmed-article:7055948 | lifeskim:mentions | umls-concept:C0868928 | lld:lifeskim |
pubmed-article:7055948 | lifeskim:mentions | umls-concept:C0750491 | lld:lifeskim |
pubmed-article:7055948 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:7055948 | pubmed:dateCreated | 1982-4-22 | lld:pubmed |
pubmed-article:7055948 | pubmed:abstractText | We evaluated a diagnostic strategy by studying 481 patients suspected of having had an acute myocardial infarction; the prevalence of infarction by independent criteria was 0.43. This strategy is based on the sequential application of: (a) clinical criteria; (b) total creatine kinase determinations in two serum samples drawn within 10 to 20 h of the onset of acute symptoms; and (c) creatine kinase B-subunit (S-CK B) determinations after immunoinhibition with antibodies to creatine kinase M-subunit in the reaction medium in all samples found to have increased total creatine kinase activity. Discrimination limits of 150 U/L total creatine kinase for women and 200 U/L for men gave a diagnostic sensitivity of 0.99. Activities less than these limits in samples identified 68% of the 274 non-infarct cases (posterior probability of a negative result of 0.99) within 20 h. Subsequent determination of S-CK B in 292 patients who were positive by the discrimination limits for total creatine kinase verified myocardial infarction in 99% of 207 cases for which S-CK B exceeded the discrimination limit of 12 U/L. The strategy excluded 98% of all non-infarct cases at a posterior probability of 0.99. | lld:pubmed |
pubmed-article:7055948 | pubmed:language | eng | lld:pubmed |
pubmed-article:7055948 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7055948 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:7055948 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7055948 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7055948 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7055948 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7055948 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7055948 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7055948 | pubmed:month | Feb | lld:pubmed |
pubmed-article:7055948 | pubmed:issn | 0009-9147 | lld:pubmed |
pubmed-article:7055948 | pubmed:author | pubmed-author:HofvendahlSS | lld:pubmed |
pubmed-article:7055948 | pubmed:author | pubmed-author:WaldenströmJJ | lld:pubmed |
pubmed-article:7055948 | pubmed:author | pubmed-author:BaggerPP | lld:pubmed |
pubmed-article:7055948 | pubmed:author | pubmed-author:GerhardtWW | lld:pubmed |
pubmed-article:7055948 | pubmed:author | pubmed-author:HörderMM | lld:pubmed |
pubmed-article:7055948 | pubmed:author | pubmed-author:BillströmRR | lld:pubmed |
pubmed-article:7055948 | pubmed:author | pubmed-author:BerningHH | lld:pubmed |
pubmed-article:7055948 | pubmed:author | pubmed-author:LjungdahlRR | lld:pubmed |
pubmed-article:7055948 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7055948 | pubmed:volume | 28 | lld:pubmed |
pubmed-article:7055948 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7055948 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:7055948 | pubmed:pagination | 277-83 | lld:pubmed |
pubmed-article:7055948 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:7055948 | pubmed:meshHeading | pubmed-meshheading:7055948-... | lld:pubmed |
pubmed-article:7055948 | pubmed:meshHeading | pubmed-meshheading:7055948-... | lld:pubmed |
pubmed-article:7055948 | pubmed:meshHeading | pubmed-meshheading:7055948-... | lld:pubmed |
pubmed-article:7055948 | pubmed:meshHeading | pubmed-meshheading:7055948-... | lld:pubmed |
pubmed-article:7055948 | pubmed:meshHeading | pubmed-meshheading:7055948-... | lld:pubmed |
pubmed-article:7055948 | pubmed:meshHeading | pubmed-meshheading:7055948-... | lld:pubmed |
pubmed-article:7055948 | pubmed:meshHeading | pubmed-meshheading:7055948-... | lld:pubmed |
pubmed-article:7055948 | pubmed:meshHeading | pubmed-meshheading:7055948-... | lld:pubmed |
pubmed-article:7055948 | pubmed:meshHeading | pubmed-meshheading:7055948-... | lld:pubmed |
pubmed-article:7055948 | pubmed:meshHeading | pubmed-meshheading:7055948-... | lld:pubmed |
pubmed-article:7055948 | pubmed:meshHeading | pubmed-meshheading:7055948-... | lld:pubmed |
pubmed-article:7055948 | pubmed:meshHeading | pubmed-meshheading:7055948-... | lld:pubmed |
pubmed-article:7055948 | pubmed:meshHeading | pubmed-meshheading:7055948-... | lld:pubmed |
pubmed-article:7055948 | pubmed:meshHeading | pubmed-meshheading:7055948-... | lld:pubmed |
pubmed-article:7055948 | pubmed:year | 1982 | lld:pubmed |
pubmed-article:7055948 | pubmed:articleTitle | Creatine kinase and creatine kinase B-subunit activity in serum in cases of suspected myocardial infarction. | lld:pubmed |
pubmed-article:7055948 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7055948 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7055948 | lld:pubmed |